Patent Application Publication ( 10) Pub

Patent Application Publication ( 10) Pub

US 20190270992A1 ( 19) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2019 /0270992 A1 BRESNICK et al. (43 ) Pub . Date : Sep . 5 , 2019 ( 54 ) METHODS OF CONTROLLING RED BLOOD (52 ) U . S . CI. CELL PRODUCTION CPC . .. .. C12N 15 / 113 ( 2013 .01 ) ; C12N 5 /0641 (2013 .01 ) ; A61K 33 / 30 ( 2013 .01 ) ; A61K 45 / 06 ( 71 ) Applicant: WISCONSIN ALUMNI RESEARCH ( 2013 . 01 ) ; A61K 31 / 7088 ( 2013 .01 ) ; ACIK FOUNDATION , MADISON , WI (US ) 35 / 18 (2013 .01 ) ; C12N 2310 / 14 ( 2013 . 01 ) ; C12N 2506 / 11 (2013 . 01 ) ; C12N 2501 / 999 (72 ) Inventors : EMERY H . BRESNICK , ( 2013 . 01 ) ; C12N 2501 / 90 ( 2013 .01 ) ; C12N MIDDLETON , WI (US ); NOBUYUKI 2310 / 122 ( 2013 .01 ) ; CI2N 2310 / 531 TANIMURA , KITA -KU ( JP ) ( 2013 .01 ) ; C12N 2506 /03 ( 2013 .01 ) (21 ) Appl. No. : 16 /292 , 922 (57 ) ABSTRACT A method of controlling red blood cell production includes ( 22 ) Filed : Mar. 5 , 2019 contacting red blood cell precursors with a composition including zinc , a composition including an inhibitor of a zinc Related U . S . Application Data exporter protein , or a combination thereof; wherein the (60 ) Provisionalapplication No .62 / 638 , 563, filed on Mar . contacting promotes survival of the red blood cell precur 5 , 2018 sors , promotes terminal differentiation of the red blood cell precursors to mature red blood cells , or a combination Publication Classification thereof; or contacting red blood cell precursors with a ( 51 ) Int. Cl. composition including a zinc chelator, a composition includ C12N 15 / 113 ( 2006 .01 ) ing an inhibitor of a zinc importer protein , or a combination C12N 5 /078 ( 2006 . 01 ) thereof ; wherein the contacting inhibits survival of the red A61K 3330 ( 2006 .01 ) blood cell precursors, inhibits terminal differentiation of the A61K 45 /06 ( 2006 . 01 ) red blood cell precursors to mature red blood cells , or a A61K 31 / 7088 ( 2006 .01 ) combination thereof . A61K 35 / 18 ( 2006 .01 ) Specification includes a Sequence Listing . Erythroid Maturation Zing Transporter Switch Here L . .. .. Exporter Slc30a1 Importer Sic39a8 Intracellular Zinc GATA . gove Heme Importer Experter impostos Exporter { Zinc ) [Zinc ] SurvivalDifferentiation Terminal Differentiation Patent Application Publication Sep . 5 , 2019 Sheet 1 of 31 US 2019 / 0270992 A1 WT Double Mutant miminimin tim timinimiminna n GATA - 1 Alas2 Alas2 ALAS - 2 ALAS - 2 Heme + B - estradiol FIG . IA GATA - 1 -regulated proteins Alas2 - enhancer- regulated proteins Para SLC4A ) H88 -81 GATA - 2 HBE -B1 SLC4A1 month Cutoeoop ** * fanyesd)"*601- BACH1 ALAS - 2 ALAS EF2S1m EF3K ER2S F3K @ AU numpaunanny of 1111111111111111 11 Fold change : log , Est + WTV/ EST - WT1 ) Fold change: 0g , (Est Mutt ! Est + WT1) < 0 .05 and Fold change (log , transfornec ): >> 1 > 0 , 05 P < 0 .05 and Fold change (log , transformed ) < 1 FIG . 1B Patent Application Publication Sep . 5 , 2019 Sheet 2 of 31 US 2019 /0270992 A1 GATA - 1 - activated GATA - 1 - repressed RNA - seq (3431 ) RNA - seq ( 3781) Proteomics 472 | 637 3144 FIG . 1C Alas2 - enhancer- activated Alas2 - enhancer- repressed RNA - Seq (738 ) ANA -Seq (602 ) 1608 _ 35 ) 703 230 135 ) 567 FIG . ID Patent Application Publication Sep . 5 , 2019 Sheet 3 of 31 US 2019 /0270992 A1 EF3K U23 SLC4A1 is EF251 FIG.1E Mut1 w B1-HBB teistele WTT BACHT 600 4Q opens * mutang mengenai angan p ) units Relative( ) units Relative( @ intensities Peptide intensities Peptide Patent Application Publication Sep . 5 , 2019 Sheet 4 of 31 US 2019 / 0270992 A1 ANA - Sea 66 GATA Theme activated genes Proteomics 3323 4 not detected others GATA - 1 / Alas2 - enhancer - activated 3 : GATA - 1 - activated & Alas2 -enhancer activated Globin Ubiquitin (0 . 5 < Fold change (log , transformed ): < 1 ) Fbxo30 Srunt 3 : GATA - 1 - activated Ube20 2 Alas2anhancer- activated Hbb -bh1 Tubb2a Slc30a ) . W . ti proteins " activatedWAW proteins LC30A1 HBB -B1 HBB -B1017 HBA - X SLC30A1 HBA- X ?????? , -109(Pvalue) BX030 . HBB -B200 H BB HBB- BH1 SRXN1 3102 SRXN1 TUBB2A UBE20 KIF2A L TUBB2A 0 2 4 6 8 10 - 10 8 6 4 2 0 Fold change log , (Est WT1 / Est- WT1) log , (Est + Mutt/ Est* WT1 ) P < 0 .05 and Fold change ( log , transformed ) > 1 P < 0 .05 and (Fold change (log , transformed ) < 1 M FIG . 1F Patent Application Publication Sep . 5 , 2019 Sheet 5 of 31 US 2019 /0270992 A1 . o Est + WT1 . O Est- Mutt . O Est + Muti . .. 60 . 0 0 . 20. 60. 60 . FIG . 2 Sic30 faniily ( Zinc exporter ) Sic39 family (Zinc importer ) 1 2 3 4 5 6 7 8 10 1 2 3 4 5 6 7 8 9 10 11 12 13 14 WT1 - Est Normalized TPM FIG . 3A Zinc exporter Zinc importer Sla30a1 Sic39a8 MRNALevels (PelativeUnits) winning L 0 .0 5 - ALA : - inti/8Muti? int1/8Mut2 WT int1/8Mutiara int1/8Mut24 WT3 int1/8Mut1 int1/6 - estradiot hy B -estradiol - B - estradiol 6 - estradiol FIG . 3B Patent Application Publication Sep . 5 , 2019 Sheet 6 of 31 US 2019 /0270992 A1 SLC30A10 wi SLC39A10 . SLC30A6 FIG.3C SLC30A5 SLC39A7 w w . olen aina my SLC30A1 olen SLC39A6 - namume namwanammed ) units Relative( intensities peptideestradiol D- intensities Peptide Patent Application Publication Sep . 5 , 2019 Sheet 7 of 31 US 2019 / 0270992 A1 R2 18 .2 R3 > -CD71 SA12 . MUS STRA. * ** W . wuuuuuuuuuuuuuuuuuuu %livecells R1 R2 R3 R4 /5 10 % 0 10 % 10 10 % - Ter119 FIG . 4A Slc30a1 (Zinc exporter ) O Slc39a8 (Zinc importer ) Hbb -b1 MRNALevels(Relativeunits) yyyyy R1 R2 R3 R475 R1 R2 R3 R4/ 5 FIG . 4B Patent Application Publication Sep . 5 , 2019 Sheet 8 of 31 US 2019 / 0270992 A1 20 OOOOOOOSSS hereTotal 20 PRIDR2R3R4 16 Hemsfrom OXYHO,6 13 ) pm( call / Herre 20 Day witament Day:9 Succinylacetone(SA) ) % ( Population 82.0 Differentiation3 Day20(SA) CD235a 54.30940 ?????????????????????????????????????????? TY 56789012121314151617181920 Day20 33.30182 Differentiation2 yyyyR31072 FIG.4C Day16 310R2 9.9902000 Differentiation1 Day13 Sorel02.962 lR3104A2 l Julebe Expansion D CD71 Patent Application Publication Sep . 5 , 2019 Sheet 9 of 31 US 2019 / 0270992 A1 Day 3 : Day 2049A • . - - FIG . 4D F13A1 SLCIQAT SLC29A8 ? MANALevels(Helativeunits) nothese ALL ?lay : in 15ATTAS 200 10 15 A 20 0 15 20 0 .0 FIG . 4E HEAT SLC30A1 SLC39A8 ACIB MANALevels {Relativeunits) 3 .LoL ALL . mirror por t finiiiiier rete day 19 20 39 20 19 20 19 20 FIG . 4F Patent Application Publication Sep . 5 , 2019 Sheet 10 of 31 US 2019 / 0270992 A1 . , , , , , , , , , . .. * . D PoE Ortho . , , , , , , , , , . : : : : : : : : : : : : : : : . Slc30 family ( Zinc exporter ) SQUI Sic39 family (Zinc importer) . .. .. Y . S . $ . ment. W . : : : : : : : : : . R2 . X . $ < . Relativeunits 2000 . 2000 . : : . .. ) . , ' , . ' . , , ' , . powiniinimumininiaisumisieireire C . .. : : : : : : : : : : : : 2 . Ni : : : : : : : : S . .. yolongannnnnnnnnnnnnnn asian ? . 1 2 3 4 5 6 7 8 10 1 2 3 4 5 6 7 8 9 10 11 12 13 14 ' ' . - . IV N A • • • , Aja S E T ' ' ' • • • 2000 SLC30 family (Zinc exporters Duowo SL439WWWVTORY family (Zinc I importer ) UBUNH Relativeunits 30000 10 . who camerieriguarantee . 1 2 3 5 6 7 8 10 1 2 3 4 5 6 7 8 9 10 11 12 13 14 FIG . 5 Patent Application Publication Sep . 5 , 2019 Sheet 11 of 31 US 2019 /0270992 A1 . 9 . " . ' Ter119 . ' . 11 . LOR O NARYONO . CD71 . Y: . 3 R . :. · . .. ASSAS24 . t 122 . Yir . 23 . 2 . 7. : . 2 . R17 5. 21 . 73 . 3 . * . .* . , , , , , , , ' , ' , ' , ' ' ' . ' , , ' , i , ' , * * * * * . - . ' . 2 . Y . V . 3 . V21 .OOO . ??????????????????????????????????????????????????????????????????????????????????????????????????????? - Ter119 CD71high CD71 high FSC.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    54 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us